Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.90)
# 3,620
Out of 4,831 analysts
86
Total ratings
25.71%
Success rate
-18.79%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $33.27 | +29.25% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $2.5 → $1.5 | $0.22 | +575.68% | 4 | May 14, 2025 | |
| XGN Exagen | Maintains: Buy | $7 → $8 | $5.75 | +39.13% | 3 | May 13, 2025 | |
| QTRX Quanterix | Maintains: Buy | $15 → $12 | $4.35 | +175.86% | 6 | May 13, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $9.53 | +57.40% | 8 | May 12, 2025 | |
| ILMN Illumina | Maintains: Hold | $92 → $87 | $79.64 | +9.24% | 10 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $16.52 | +124.04% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $41.14 | +58.00% | 6 | May 1, 2025 | |
| AKYA Akoya Biosciences | Maintains: Hold | $3.5 → $1.8 | $0.97 | +85.91% | 4 | Apr 29, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $128.54 | +16.70% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.13 | +165.49% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $151.25 | +28.93% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.16 | +159.74% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $1.49 | -32.66% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $52.28 | +43.46% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.48 | +313.74% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.73 | +6,680.60% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.92 | +384.69% | 1 | Jan 29, 2021 |
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $33.27
Upside: +29.25%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.22
Upside: +575.68%
Exagen
May 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.75
Upside: +39.13%
Quanterix
May 13, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $4.35
Upside: +175.86%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $9.53
Upside: +57.40%
Illumina
May 12, 2025
Maintains: Hold
Price Target: $92 → $87
Current: $79.64
Upside: +9.24%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $16.52
Upside: +124.04%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $41.14
Upside: +58.00%
Akoya Biosciences
Apr 29, 2025
Maintains: Hold
Price Target: $3.5 → $1.8
Current: $0.97
Upside: +85.91%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $128.54
Upside: +16.70%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $151.25
Upside: +28.93%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.16
Upside: +159.74%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.49
Upside: -32.66%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $52.28
Upside: +43.46%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.48
Upside: +313.74%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.73
Upside: +6,680.60%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.92
Upside: +384.69%